Rowhammer attacks have been around since 2014, and mitigations are in place in most modern systems, but the team at gddr6.fail has found ways to apply the attack to current-generation GPUs.

Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...